Logan Trim

Logan Trim is a researcher affiliated with Queensland University of Technology (QUT), focusing on vaccine development, immunopathology, and infectious diseases. His work primarily addresses Chlamydia infections, genital tract immunity, and the development of novel vaccination strategies. Trim completed his PhD in 2024, titled The Development of an Effective Vaccine to Protect Against Female Genital Tract Chlamydial Infections, which highlights his specialization in mucosal immunity.

Key research interests include T-cell responses to viral vectors, the role of IL-17A in immunopathology, and the neuroinvasive potential of Chlamydia species. His studies span both basic science (e.g., antigen stability, DNA damage mechanisms) and translational research (e.g., controlled-release vaccine implants, murine infection models). Trim collaborates extensively with groups studying reproductive health impacts of infections, as evidenced by co-authored papers on sperm health preservation and testicular pathology.

Publications demonstrate expertise in immunology, microbiology, and vaccine design. His work bridges clinical and laboratory settings, addressing both pathogenic mechanisms and therapeutic interventions.